Dear colleagues,
With GAVI's recent announcement incorporating the category of TPVS active vaccine carriers into the Cold Chain Equipment Optimization Platform (CCEOP), I wanted to open up a discussion to gather your inputs and suggestions on this development.
As immunization professionals, we are aware of the critical role cold chain equipment plays in ensuring vaccine potency and delivery. The inclusion of TPVS active carriers in CCEOP raises several interesting considerations:
-
Relevance and Use Cases:
- How relevant are TPVS active vaccine carriers in your operational context?
- Do you see them addressing specific gaps that current equipment may not fully meet?
-
Performance and Practicality:
- What are your thoughts on the reliability and practicality of these devices in field conditions, especially in hard-to-reach areas?
- Are there challenges in integrating TPVS technology into your existing workflows?
-
Impact of CCEOP Inclusion:
- What could this inclusion mean for funding, accessibility, and adoption of these devices?
- Are there any particular considerations or support mechanisms you'd expect to ensure successful implementation?
Your insights will be invaluable in shaping how we collectively understand and utilize this category of equipment. Please feel free to share your experiences, concerns, or questions related to TPVS carriers.
Looking forward to a robust and insightful discussion!